{
    "title": "After Merck success, work goes on with other Ebola vaccines",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3181463/After-Merck-success-work-goes-Ebola-vaccines.html",
    "date": "2015-07-31",
    "keywords": [
        "vaccine",
        "success",
        "research",
        "trial",
        "university",
        "development",
        "work",
        "gmt",
        "july",
        "ben",
        "ebola",
        "use",
        "director",
        "world",
        "number",
        "email",
        "hirschlerlondon",
        "drug",
        "potential",
        "shot",
        "merck",
        "newlink",
        "population",
        "groupsbecause",
        "safety",
        "event",
        "flu",
        "virologist",
        "neuman",
        "womenreplicating",
        "advantage",
        "dose",
        "emergency",
        "epidemicthere",
        "place",
        "order",
        "competitionmsf",
        "health",
        "organization",
        "verge",
        "ebolaglaxosmithkline",
        "vaccinewe",
        "community",
        "control",
        "vaccination",
        "statementgsk",
        "guinea",
        "marie",
        "paule",
        "kieny",
        "casesjohnson",
        "johnson",
        "twoinjection",
        "partnership",
        "nordic",
        "programme",
        "sierra",
        "leone",
        "stage",
        "team",
        "texas",
        "vaccineadrian",
        "hill",
        "jenner",
        "institute",
        "oxford",
        "midstage",
        "epidemic",
        "response",
        "primate",
        "reporting",
        "geneva",
        "editing",
        "hardcastle"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}